|
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations |
Aug 2024 |
Pediatric Blood Cancer |
Aplastic Anemia, Pediatric |
|
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations |
May 2024 |
Pediatric Blood & Cancer |
Aplastic Anemia |
|
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort |
Aug 2020 |
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
|
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium |
Aug 2020 |
Pediatric Blood & Cancer |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric |
|
Eltrombopag in children with severe aplastic anemia |
Apr 2021 |
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
|
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version |
Oct 2024 |
PDQ Cancer Information Summaries |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic Syndromes Treatment (PDQ®): Health Professional Version |
Sep 2024 |
PDQ Cancer Information Summaries |
Myelodysplastic Syndromes (MDS) |
|
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
Dec 2023 |
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
|
Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United States |
Dec 2024 |
Oncology and Therapy |
Myelodysplastic Syndromes (MDS) |
|
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes |
Oct 2023 |
Oncologist |
Myelodysplastic Syndromes (MDS) |
